CIK 0001426800 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in DE · fiscal year ends 12/31
| FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|
| Revenue (USD) | 72.3 M | |||
| Net income (USD) | -93.1 M | -129.9 M | ||
| Diluted EPS (USD/shares) | -0.55 | -13.38 | -23.08 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-08-20 | S-8 | S-8 | |
| 2026-08-14 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-08-14 | 8-K/A | 8-K/A items 2.02,9.01 | 2026-08-13 |
| 2026-08-13 | 10-Q | 10-Q | 2026-06-30 |
| 2026-08-13 | 8-K | 8-K items 2.01,9.01 | 2026-08-13 |
| 2026-08-13 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-08-04 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-06-18 | 4 | 4 | 2026-06-17 |
| 2026-06-05 | 4 | 4 | 2026-03-29 |
| 2026-06-05 | 4 | 4 | 2026-03-29 |
| 2026-06-05 | 4 | 4 | 2026-06-04 |
| 2026-06-05 | 4 | 4 | 2026-06-04 |
| 2026-06-05 | 4 | 4 | 2026-06-04 |
| 2026-06-05 | 4 | 4 | 2026-06-04 |
| 2026-06-05 | 4 | 4 | 2026-06-04 |
| 2026-06-05 | 4 | 4 | 2026-06-04 |
| 2026-06-05 | 4 | 4 | 2026-03-29 |
| 2026-06-05 | 4 | 4 | 2026-03-29 |
| 2026-06-05 | 4 | 4 | 2026-03-29 |
| 2026-06-05 | 8-K | 8-K items 5.02,5.07,9.01 | 2026-06-04 |
| 2026-05-27 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 2026-05-26 |
| 2026-05-27 | SCHEDULE 13D/A | SCHEDULE 13D/A | |
| 2026-05-26 | 8-K | 8-K items 1.01,8.01,9.01 | 2026-05-21 |
| 2026-05-26 | 424B5 | 424B5 | |
| 2026-05-22 | 424B5 | 424B5 |
Forms on file (last 1,000): 4 266, 8-K 187, SC 13G/A 60, 10-Q 47, 3 39, SC 13G 37, 424B5 21, DEFA14A 20. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=ASMB (0.002 USD), /gw/filings/filings?ticker=ASMB&form=8-K, /gw/filings/facts?ticker=ASMB&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange